1.19
-0.01(-0.83%)
Currency In USD
| Previous Close | 1.2 |
| Open | 1.19 |
| Day High | 1.22 |
| Day Low | 1.18 |
| 52-Week High | 3.04 |
| 52-Week Low | 1 |
| Volume | 23,376 |
| Average Volume | 212,953 |
| Market Cap | 8.11M |
| PE | 9.92 |
| EPS | 0.12 |
| Moving Average 50 Days | 1.9 |
| Moving Average 200 Days | 1.62 |
| Change | -0.01 |
If you invested $1000 in Intelligent Bio Solutions Inc. (INBS) since IPO date, it would be worth $0.45 as of April 19, 2025 at a share price of $1.19. Whereas If you bought $1000 worth of Intelligent Bio Solutions Inc. (INBS) shares 3 years ago, it would be worth $6.08 as of April 19, 2025 at a share price of $1.19.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System
GlobeNewswire Inc.
Mar 31, 2025 12:30 PM GMT
Integration of Arabic opens opportunities in the Middle East and supports Company’s strategic global expansion goals Drug Screening Reader - Arabic INBS' Drug Screening System now supports the Arabic language. NEW YORK, March 31, 2025 (GLOBE NEW
Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show
GlobeNewswire Inc.
Mar 28, 2025 12:30 PM GMT
NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its participation as a
Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra
GlobeNewswire Inc.
Mar 27, 2025 1:00 PM GMT
INBS set to capitalize on growing Spanish Drug Testing Market, anticipated to reach $448 million by 2030 Major Spanish accounts currently require 1,000 drug testing cartridges per month NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio
Data not available